Implementation of personalized multidisciplinary neuropathy management program for chemotherapy-induced peripheral neuropathy symptoms in breast cancer patients

References

• Barzaman K, Karami J, Zarei Z, et al. Breast cancer: biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535. doi: 10.1016/j.intimp.2020.106535.
   PubMed Web of Science ®Google Scholar
• Di Nardo P, Lisanti C, Garutti M, et al. Chemotherapy in patients with early breast cancer: clinical overview and management of long-term side effects. Expert Opin Drug Saf. 2022;21(11):1341–1355. doi: 10.1080/14740338.2022.2151584.
   PubMed Web of Science ®Google Scholar
• Zhang S. Chemotherapy-induced peripheral neuropathy and rehabilitation: a review. Semin Oncol. 2021;48(3):193–207. doi: 10.1053/j.seminoncol.2021.09.004.
   PubMed Web of Science ®Google Scholar
• Altinisik M, Arikan F. “Individualized care” from the viewpoint of Turkish patients and oncology nurses. Cancer Nurs. 2022;45(6):E903–e913. doi: 10.1097/NCC.0000000000001057.
   PubMed Web of Science ®Google Scholar
• Işık MT, Yıldırım G. Individualized care perceptions and moral distress of intensive care nurses. Nurs Crit Care. 2023;28(2):184–192. doi: 10.1111/nicc.12715.
   PubMed Web of Science ®Google Scholar
• López-Domingo B, Rodríguez-Martín B. Factors associated with the provision of individualized care during hospitalization: a systematic review. J Nurs Manag. 2021;29(2):113–132. doi: 10.1111/jonm.13150.
   PubMed Web of Science ®Google Scholar
• Selvy M, Kerckhove N, Pereira B, et al. Prevalence of chemotherapy-Induced peripheral neuropathy in multiple myeloma patients and its impact on quality of life: a single center Cross-Sectional study. Front Pharmacol. 2021;12:637593. doi: 10.3389/fphar.2021.637593.
   PubMed Web of Science ®Google Scholar
• Jordan B, Margulies A, Cardoso F, et al. Systemic anticancer therapy-induced peripheral and Central neurotoxicity: ESMO-EONS-EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31(10):1306–1319. doi: 10.1016/j.annonc.2020.07.003.
   PubMed Web of Science ®Google Scholar
• Argyriou AA, Park SB, Islam B, et al. Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings. J Neurol Neurosurg Psychiatry. 2019;90(12):1361–1369. doi: 10.1136/jnnp-2019-320969.
   PubMed Web of Science ®Google Scholar
• Tamburin S, Park SB, Schenone A, et al. Rehabilitation, exercise, and related non-pharmacological interventions for chemotherapy-induced peripheral neurotoxicity: systematic review and evidence-based recommendations. Crit Rev Oncol Hematol. 2022;171:103575. doi: 10.1016/j.critrevonc.2021.103575.
   PubMed Web of Science ®Google Scholar
• Zhi WI, Baser RE, Kwon A, et al. Characterization of chemotherapy-induced peripheral neuropathy using patient-reported outcomes and quantitative sensory testing. Breast Cancer Res Treat. 2021;186(3):761–768. doi: 10.1007/s10549-020-06079-2.
   PubMed Web of Science ®Google Scholar
• Bonomo R, Cavaletti G. Clinical and biochemical markers in CIPN: a reappraisal. Rev Neurol (Paris). 2021;177(8):890–907. doi: 10.1016/j.neurol.2020.11.001.
   PubMed Web of Science ®Google Scholar
• Freites-Martinez A, Santana N, Arias-Santiago S, et al. Using the common terminology criteria for adverse events (CTCAE - Version 5.0) to evaluate the severity of adverse events of anticancer therapies. CTCAE versión 5.0. Actas Dermosifiliogr (Engl Ed). 2021;112(1):90–92. doi: 10.1016/j.ad.2019.05.009.
   PubMed Web of Science ®Google Scholar
• Parsons SK, Rodday AM, Pei Q, et al. Performance of the FACT-GOG-ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the children’s oncology group AHOD 1331 study. J Patient Rep Outcomes. 2023;7(1):113. doi: 10.1186/s41687-023-00653-0.
   PubMedGoogle Scholar
• Calhoun EA, Welshman EE, Chang CH, et al. Psychometric evaluation of the functional assessment of cancer therapy/gynecologic oncology group-neurotoxicity (fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. Int J Gynecol Cancer. 2003;13(6):741–748. doi: 10.1136/ijgc-00009577-200311000-00003.
   PubMed Web of Science ®Google Scholar
• Tabrizi FM, Alizadeh S. Cancer related fatigue in breast cancer survivors: in correlation to demographic factors. Maedica (Bucur). 2017;12(2):106–111.
   PubMedGoogle Scholar
• Okuyama T, Akechi T, Kugaya A, et al. Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manage. 2000;19(1):5–14. doi: 10.1016/s0885-3924(99)00138-4.
   PubMed Web of Science ®Google Scholar
• Costantini L, Pasquarella C, Odone A, et al. Screening for depression in primary care with patient health questionnaire-9 (PHQ-9): a systematic review. J Affect Disord. 2021;279:473–483. doi: 10.1016/j.jad.2020.09.131.
   PubMed Web of Science ®Google Scholar
• Sun Y, Fu Z, Bo Q, et al. The reliability and validity of PHQ-9 in patients with major depressive disorder in psychiatric hospital. BMC Psychiatry. 2020;20(1):474. doi: 10.1186/s12888-020-02885-6.
   PubMed Web of Science ®Google Scholar
• Lee C, Round JM, Hanlon JG, et al. Generalized anxiety disorder 7-Item (GAD-7) scores in medically authorized cannabis patients-Ontario and Alberta, Canada. Can J Psychiatry. 2022;67(6):470–480. doi: 10.1177/07067437211043393.
   PubMed Web of Science ®Google Scholar
• Dhira TA, Rahman MA, Sarker AR, et al. Validity and reliability of the generalized anxiety disorder-7 (GAD-7) among university students of Bangladesh. PLoS One. 2021;16(12):e0261590. doi: 10.1371/journal.pone.0261590.
   PubMed Web of Science ®Google Scholar
• Hu W, Li T, Cao S, et al. Influence of Nurse-Led health education on self-management ability, satisfaction, and compliance of elderly patients with chronic obstructive pulmonary disease based on knowledge, belief, and practice model. Comput Math Methods Med. 2022. 2022;2022:1782955. doi: 10.1155/2022/1782955.
   PubMed Web of Science ®Google Scholar
• GraphPad Software. 2020. GraphPad prism (version 8.0). San Diego, CA: GraphPad Software.
   Google Scholar
• IBM Corp. 2019. IBM SPSS statistics for windows, version 26.0. Armonk, NY: IBM Corp.
   Google Scholar
• Fox RS, Ancoli-Israel S, Roesch SC, et al. Sleep disturbance and cancer-related fatigue symptom cluster in breast cancer patients undergoing chemotherapy. Support Care Cancer. 2020;28(2):845–855. doi: 10.1007/s00520-019-04834-w.
   PubMed Web of Science ®Google Scholar
• Cyr AE, Kennard K. Individualizing breast cancer risk assessment in clinical practice. Surg Oncol Clin N Am. 2023;32(4):647–661. doi: 10.1016/j.soc.2023.05.013.
   PubMed Web of Science ®Google Scholar
• Tandon M, Yacur M, Brenin C, et al. Cryotherapy for prevention of chemotherapy induced peripheral neuropathy in breast cancer. Crit Rev Oncol Hematol. 2024;194:104244. doi: 10.1016/j.critrevonc.2023.104244.
   PubMed Web of Science ®Google Scholar
• Claessens AKM, Ibragimova KIE, Geurts SME, et al. The role of chemotherapy in treatment of advanced breast cancer: an overview for clinical practice. Crit Rev Oncol Hematol. 2020;153:102988. doi: 10.1016/j.critrevonc.2020.102988.
   PubMed Web of Science ®Google Scholar
• Sartain AF. Quizzing in baccalaureate nursing education and the impact on national council licensure examination for registered nurses success. J Mod Nurs Pract Res. 2023; doi: 10.53964/jmnpr.2023019
   Google Scholar